The Clorox Company $CLX Position Lifted by Quantinno Capital Management LP

Quantinno Capital Management LP grew its stake in shares of The Clorox Company (NYSE:CLX) by 280.2% in the 1st quarter, Holdings Channel.com reports. The fund owned 200,106 shares of the company’s stock after purchasing an additional 147,480 shares during the quarter. Quantinno Capital Management LP’s holdings in Clorox were worth $20,737,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of CLX. Haverford Trust Co lifted its position in shares of Clorox by 2.8% during the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after purchasing an additional 84 shares during the last quarter. Field & Main Bank grew its stake in Clorox by 3.3% in the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in Clorox by 28.2% in the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after buying an additional 100 shares during the last quarter. Kestra Private Wealth Services LLC raised its stake in Clorox by 1.8% during the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after buying an additional 104 shares in the last quarter. Finally, Johnson Financial Group Inc. lifted its holdings in Clorox by 3.1% during the 3rd quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after buying an additional 109 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.1%

Shares of Clorox stock opened at $95.66 on Friday. The business’s fifty day moving average price is $95.51 and its two-hundred day moving average price is $103.67. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The company has a market capitalization of $11.57 billion, a P/E ratio of 15.53 and a beta of 0.54. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $128.90.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. Clorox’s revenue was up .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.45 EPS. As a group, research analysts forecast that The Clorox Company will post 5.52 EPS for the current year.

Analysts Set New Price Targets

CLX has been the subject of several research reports. UBS Group lifted their target price on Clorox from $96.00 to $100.00 and gave the stock a “neutral” rating in a research report on Thursday, July 16th. Royal Bank Of Canada dropped their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Barclays raised their price objective on Clorox from $85.00 to $86.00 and gave the stock an “underweight” rating in a research note on Tuesday, July 21st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. Finally, Jefferies Financial Group lowered shares of Clorox from a “buy” rating to a “hold” rating and lowered their target price for the company from $125.00 to $98.00 in a research note on Tuesday. Twelve research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $101.00.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.63% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.